BioSpace News Archive

Instead of going through pharma job search websites, you should create a powerful LinkedIn profile. Check out Biospace to find out the benefits of having a strong LinkedIn Profile.

Ascletis Pharma Inc. announces the approval of the Investigational New Drug application by U.S. Food and Drug Administration for in-house developed oral PD-L1 small molecule inhibitor, ASC61, for the treatment of advanced solid tumors.

Antengene Corporation Limited announced that ATG-037 has received approval by the Bellberry Human Research Ethics Committee in Australia to initiate the Phase I STAMINA trial, a first-in-human study of ATG-037 in patients with locally advanced or metastatic solid tumors.

Celltrion Group announced it has submitted an Investigational New Drug application to conduct a global Phase III clinical trial evaluating the efficacy and safety of an inhaled COVID-19 antibody cocktail therapy for patients with mild-to-moderate symptoms of COVID-19; the trial is expected to enrol 2,200 patients globally.

The global vision care market is poised to display steadfast growth in the years ahead.

Serving as a middleman between drug manufacturers, pharmacies, and healthcare insurance companies, vendors operating in the global pharmacy benefit management services market could be advantaged by the rising costs of several drugs.

Parathyroid hormone is a single chain polypeptide made up of 84 amino acids secreted by the parathyroid gland located near the thyroid gland.

Interventional spine procedures are used to manage and treat back pain and spine conditions.

Cardiac assist catheter pumps are used to increase the output of a heart by reducing oxygen consumption, myocardial workload, and simultaneously increasing cardiac output.

Fact.MR – A Market Research and Competitive Intelligence Provider: The global medical foods industry has a market value of US$ 20 billion in 2021, and is predicted to grow at a CAGR of 5% between 2022 and 2032, amassing a market value of US$ 32.6 billion.